Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
fyi - The Food and Drug Administration announced it intends to award a contract to a company to “provide online data subscription and analytic services to help address knowledge gaps and contribute to the foundation of evidence needed on cannabidiol (CBD) and other cannabis products to help inform development of surveillance measures, guide prevention efforts, and target education/outreach initiatives.”
fyi The Food and Drug Administration announced it intends to award a contract to a company to “provide online data subscription and analytic services to help address knowledge gaps and contribute to the foundation of evidence needed on cannabidiol (CBD) and other cannabis products to help inform development of surveillance measures, guide prevention efforts, and target education/outreach initiatives.”
LOL. No, I don’t need to tell anybody they are wrong. Their companies they work for on the other hand may.
But to be fair, you didn’t mention if they are buy side or sell side. You didn’t mention if those were the projections they put out yesterday, or are they several months or longer ago. You didn't mention the last rerate.You didn’t mention if they are sponsored. And you didn’t mention what success rate their projections have been. A 10 percent rate is far different than a 90 percent rate.
You also mentioned revenue in another post. Yes, it’s very good revenue, but by itself is next to meaningless without at least mentioning that it costs more than a dollar for every dollar they take in. They are operating at a loss. So I guess with the record revenue they have record costs as well. Are there reasons, sure but failing to mention them is misleading. Kind of like a baseball team played today and scored 4 runs, did they win, lose, we don’t know do we.
So, 61 trades, 18 k- 295 per. wap- .0323. Better than yesterday
Hope all is well. Yes, great opportunity for smart people. But that boils down to selection and timing, or perhaps at times just dumb luck. Buying at the bottom, or just coming out of a recession is good times for those that timed a good selection.
Well, we know where we been, the future is not written, so sure, great things, good, fair, poor are all on the table. As far as management, genius? Who’s to say, at the end of the day they will absolutely be judged on what they did. Maybe their genius is just keeping afloat this long. Were going to see how it all plays.
You almost have to laugh. Now they say the bad times are going to be coming. So be it, I think were already there.
Remember way back to the start of the year, and this one was over .25 a share. Even in march we were at .17 a share until they out with year-end earnings.
The 1st qt conf. call with out questions. Yep, that was a hoot.
ASM which is when they went thru the motions of the vote they rigged, followed by the increase, raise they mentioned.
Milestones . . . . . . .
All I can say is fortunately they got those raises. Imagine how much worst it could have been.
Their gameplan has been to . . . . . . . .
But now if you listen to the talking heads on the economy, the bad times are coming!
So here we are, you know just 3 weeks ago or so we still have some action around a nickel. Now were having all we can do to hold 3 cents.
I think the next qt release will be reviewed, not only with a open mind, but also with no carrots, no blue sky, only what is. Show me the numbers.
First couple of hours. A little more activity today. 20 trades 3700 dollars 187 per trade.
RE: “All of this prediction stuff is a joke.” Well I'm sorry to hear that. I guess that means several hundred thousand quants and analysts and specialists are going to be out of work then. That’s a shame.
Ah yes, floundering oblivion. Nice to know your getting your jollies from it. Thanks for sharing.
Yes, they are RE: Validating the science and making moves forward. CW is leading the charge.
What do we have today. 37 trades – 6900 dollars – 186 per . We’ll call that light.
More avenues opening up. Nothing wrong with that. It's all good.
Trulieve Opening New Medical Marijuana Dispensary in Hollywood, FL
Today 7:43 AM ET (PR NewsWire)Print
New dispensary expands patient access to medical cannabis; grand opening specials available
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical dispensary in Hollywood, Florida. Located at 2908 Hollywood Blvd., the Hollywood dispensary opens at 9am on Tuesday, July 12, 2022, with ongoing regular hours of 9am - 9pm from Monday through Saturday and 10am - 8pm on Sunday.
https://mma.prnewswire.com/media/1857030/Hollywood_FL.jpg
Grand opening festivities throughout the day at the new dispensary will include numerous partner giveaways, music, food trucks, deals and specials, and all registered patients will receive a 25% discount. Trulieve also offers statewide home delivery, convenient online ordering and in-store pickup. As always, all first-time guests are eligible for a 50% new customer discount at any Florida-based location.
"Trulieve is excited to expand access to medical cannabis to more patients in Florida and build strong relationships in the Hollywood community," said Kim Rivers, CEO of Trulieve. "We are driven by our commitment to providing tailored, high-quality patient care in a safe and comfortable environment."
As the state's leading medical cannabis provider, Trulieve's retail employees are trained to provide personalized patient care and support individuals at every stage of their cannabis journeys. Trulieve dispensaries throughout Florida offer on-site consultations to help patients obtain appropriate medical products and dosages to ensure optimal cannabis experiences.
Trulieve patients across Florida can choose from the largest selection of THC and CBD products available in a variety of consumption methods, including smokable flower, concentrates, edibles, capsules, syringes, tinctures, topical creams, vaporizers, and more.
Designed to meet every patient's needs, our portfolio of in-house brands includes Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One and Sweet Talk. Patients also have access to beloved brands such as Bellamy Brothers, Bhang, Binske, Blue River, Black Tuna, DeLisioso, Love's Oven, Miami Mango, O.pen and Sunshine Cannabis, all available exclusively at Trulieve in Florida.
EXCLUSIVE: Ayr Wellness To Open Another Rec Cannabis Dispensary In Greater Boston Area
Today 6:53 AM ET (Benzinga)Print
Ayr Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF) is opening a new store in Watertown, its second retail location selling recreational marijuana in the Greater Boston area. The company will launch sales on Tuesday, July 12.
Located at 48 North Beacon Street, Watertown, Massachusetts, the store features a wide range of cannabis brands and products, including Ayr’s own Kynd premium flower, Entourage vapes, Secret Orchard vapes, Wicked edibles, Levia THC infused seltzer, and HAZE concentrates, to address experienced consumers as well as those newer to cannabis.
“The opening of AYR in Watertown is another amazing milestone for our team. We are thrilled to be adding a second adult-use dispensary in Greater Boston in another great location,” Jonathan Sandelman, founder, chairman and CEO of Ayr, said. “With our newly opened Back Bay dispensary hosting its Grand Opening Celebration on July 14th, this is an important week for Ayr in Greater Boston. We look forward to celebrating these milestones with the Watertown community, where we maintain our commitment to being a great neighbor and community partner.”
Ayr Launches Adult-Use Cannabis Sales in Watertown, the Company's Second Adult-Use Dispensary in Massachusetts
Today 7:30 AM ET (GlobeNewswire)Print
EQNX::TICKER_START (CNSX:AYR.A),(CNSX:AYR.A.CN),(OTC US:AYRWF),(Other OTC:AYRWF),(CNSX:AYR-A.CN),(CNSX:AYR-A), EQNX::TICKER_END Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("Ayr" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announced the opening of AYR in Watertown, the Company's second adult-use dispensary in the Greater Boston area. Sales will begin July 12, 2022, at 10am ET.
Located at 48 North Beacon Street, the store features a wide range of cannabis brands and products, including Ayr's own Kynd premium flower, Entourage vapes, Secret Orchard vapes, Wicked edibles, Levia THC infused seltzer, and HAZE concentrates, to address experienced consumers as well as those newer to cannabis.
"The opening of AYR in Watertown is another amazing milestone for our team. We are thrilled to be adding a second adult-use dispensary in Greater Boston in another great location," said Jonathan Sandelman, Founder, Chairman and CEO of Ayr. "With our newly opened Back Bay dispensary hosting its Grand Opening Celebration on July 14, this is an important week for Ayr in Greater Boston. We look forward to celebrating these milestones with the Watertown community, where we maintain our commitment to being a great neighbor and community partner."
The whole sector for the most part was down. This one was down on LIGHT volume. Not the massive dump as some projected ,hmmmmmmm I wonder why?
Well, let’s see. Sprout co-branded product line of children’s food with CoComelon. Baby food, maybe important, they claim they can get it up to 22 million in revenue by the end of 2024
Losses are currently are170 thousand per day, not so good. Long way to 2024
They still have Forest Remedies, the multi-Omega supplement.
The adjusted EBITDA loss during the quarter was $15.2 million.
Below is from the filing. THINK RED FLAGS
As of the date of this Annual Report, we are actively managing our liquidity and expenses, and there is substantial doubt that our current cash position will be sufficient to continue as a going concern. The Company currently has minimal available cash balances, and we are also continuing to incur expenses that will cause us to expend cash in the short term. Payables are now in excess of available cash balances and payments of payables are not being made as the amounts become due for certain suppliers. As of the date of this Annual Report, the cash balance is expected to be sufficient to operate the business for only the next two to three months under the current business plan. We have no arranged sources of financing available to us. Our failure to obtain any required additional financing on favorable terms, or at all, would have a material adverse effect on our business, financial condition and results of operations. We are pursuing several cash generating transactions, including the strategic plan described above, as well as further expense reduction measures, but there can be no assurance that any transaction will be completed or that our expense reduction measures will be sufficient to continue as a going concern.
Although our consolidated financial statements have been prepared on a going concern basis, our management believe that our recurring losses and negative cash flows from operations and other factors have raised As of the date of this Annual Report, we are actively managing our liquidity and expenses, and there is substantial doubt that our current cash position will be sufficient to continue as a going concern. The Company currently has minimal available cash balances, and we are also continuing to incur expenses that will cause us to expend cash in the short term. Payables are now in excess of available cash balances and payments of payables are not being made as the amounts become due for certain suppliers. As of the date of this Annual Report, the cash balance is expected to be sufficient to operate the business for only the next two to three months under the current business plan. We have no arranged sources of financing available to us. Our failure to obtain any required additional financing on favorable terms, or at all, would have a material adverse effect on our business, financial condition and results of operations. We are pursuing several cash generating transactions, including the strategic plan described above, as well as further expense reduction measures, but there can be no assurance that any transaction will be completed or that our expense reduction measures will be sufficient to continue as a going concern.
Well, how substantial can it be? If the price goes low enough it maybe worth the risk.
It will take some time before this gets down to a reasonable price, certainly way under a dollar, but that’s if they can manage to stay in business. IMO
Verano Opens 2 MÃœV Cannabis Dispensaries, Raising Florida Footprint To 51 Locations Statewide
Today 10:51 AM ET (Benzinga)Print
Verano Holdings Corp. (OTCQX: VRNOF) (CSE:VRNO) opened MÜV Fort Myers Cypress and MÜV Sarasota Main, the company’s 50th and 51st Florida dispensaries and 103rd nationwide. Both MÜV Fort Myers Cypress, located at 7010 Cypress Terrace, and MÜV Sarasota Main, located at 1618 Main Street, are open Monday through Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m., local time.
“Opening our third MÜV location in Fort Myers and second in Sarasota, and surpassing our 50th MÜV dispensary milestone in Florida, is an exciting achievement for Verano, our team, and the Florida medical marijuana community,” stated John Tipton, president of Verano. “We have witnessed incredible growth in the Florida medical marijuana patient population and are excited to provide more paitients with our premium cannabis products through our growing retail footprint. We’re grateful for our incredible team members and patients for helping us surpass this milestone, and look forward to a bright future ahead in the Sunshine State.”
As a demonstration of their commitment to provide a convenient and reliable experience for Florida patients, MÜV dispensaries feature online menus for browsing of their product selection, including the company’s signature Verano Reserve flower line. For additional convenience and accessibility, patients can choose to order ahead at MÜV’s website or through the MÜV mobile application available in the Google Play and Apple App stores for express in-store pickup.
MÜV offers one-on-one virtual and in-store consultations at no cost to the patient. MÜV’s comprehensive product selection includes edibles, chocolates and lozenges, flower, pre-rolls, an array of vaporizer pens, concentrates, metered-dose inhalers, topicals and oral sprays; along with patented encapsulation formulations in its EnCaps capsules, tinctures, 72-hour transdermal patches and transdermal gels.
It passed - Arrangement Resolution
At the Meeting, the Shareholders voted to pass a special resolution, the full text of which is set forth in Appendix “B” to the Circular, approving the Arrangement (as defined in the Circular) under Division 5 of Part 9 of the Business Corporations Act (British Columbia) whereby, among other things, Cresco Labs Inc. will acquire all of the issued and outstanding shares of the Company, all as more particularly described in detail in the Circular.
The following is a summary of the votes cast by all shareholders of the Company:
FOR AGAINST ABSTAIN
167,469,030 2,395,951 73,665
No wolfe, your wrong, you know your wrong, I know your wrong, we know your wrong, enough said.
No, they won’t be selling Monday, nor can they. A person should really read the sec filings. There currently 3 reasons why that can’t happen.
Regarding product. I should state I have tried many different CBD products, I prefer CVSI sleep and reserve. That being said its only a personal choice.
The market place shows CW out sells CV 4-5 to 1. Qt after QT, year after year. For what ever reason you like, the market place has spoken. CW flat out sells more.
SG&A, your dead center there, I think the person/problem has been removed regarding that. The new CEO has stated his goals on that issue, has made a dent in the first qt and I will be looking for further improvements. We’ll see.
FDA is a sore subject with me, but it does affect everybody equally, so that would not be a factor.
I think you’re on something there. Dilution is the solution. CW buys out CV for what 3.5, 4.0 million EVP worth. I don’t know if it would be that high but let’s say. CW quickly gets rid of JD the other board member left. 2 mil a year in synergy savings, pays for the company in savings in 2 years, Picks up 4 mil in product sales per qt. The best gets bigger, CV is finally put out of their misery. JD gets the golden parachute, you get the merger, everybody wins.
I mean sure you could let Cv just die out. They lost 99 percent already, clinging to those pay checks is not a business plan however, I say throw them a bone. The CW crowd won’t like the sink of CV products but it could be kept as a lower class offering. The share price goes up for CW, the misery of the CV shareholders is finally done, and all the shareholders of both companies make money. It’s a win,win,win.
I like it. It all makes sense, good call!
And why would you guess that?
Where? Enjoying summer. It seems the talk here, at least from the one liner crowd is about BK.
Since they don’t even qualify for it, in bankruptcy court that is, nor could they at any time in the near future, it would seem {1} people are very confused or {2} just want to stir the pot.
Other than selling 10 times the product, that would be nice huh, the biggest concern imo is the SG
&A. They put a dent in that last quarter and have promised to lower yet again this quarter. They get a handle on that it will make a big difference.
I mentioned, on several boards, this is going to be a long summer. Can’t really talk about this, or any other company, with out bringing in the sector first, can’t talk about the sector without bringing in the markets, which of course are being rattled about the economy. There is no clean look from here on the overall, and IMO that will remain so until early fall at the soonest.
So, I say stay aware but sit back and enjoy some summer.
Are you confused? There are 145.28 million outstanding shares. You said " I cant believe anyone would invest in a company with UNLIMITED OUTSTANDING SHARES! "
What are you talking about?
FYI - PLAN OF DISTRIBUTION
{ my note. This is a continuation from the filings of 1/21, 2/21. And IMO it is worth being aware of, not to be confused with being scared of} also of note if your just rapid trading this one you can save yourself the read imo.
The Subordinate Voting Shares beneficially owned by the Selling Shareholders covered by this prospectus may be offered and sold from time to time by the Selling Shareholders. The term “Selling Shareholders” includes donees, pledgees, transferees or other successors in interest selling shares received after the date of this prospectus from a Selling Shareholder as a gift, pledge, partnership distribution or other non-sale related transfer. The Selling Shareholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more exchanges or in the over-the-counter market or otherwise, at prices and under terms then prevailing or at prices related to the then current market price or in negotiated transactions. The Selling Shareholders may sell or dispose of their shares by one or more of, or a combination of, the following methods:
purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus;
ordinary brokerage transactions and transactions in which the broker solicits purchasers;
block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;
an exchange distribution in accordance with the rules of any stock exchange on which the securities are listed;
through trading plans entered into by a Selling Shareholder pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans;
to or through underwriters;
in “at the market” offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents;
in privately negotiated transactions;
in short sales;
through the distribution of the securities by any Selling Shareholder to its partners, members or shareholders;
in options transactions; and
through a combination of any of the above methods of sale and, in addition, any shares that qualify for sale pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to this prospectus.
The Selling Shareholders will pay all brokerage fees and commissions and similar expenses. We will pay all expenses (except brokerage fees and commissions and similar expenses) relating to the registration of the Subordinate Voting Shares with the SEC.
To the extent required, this prospectus may be amended or supplemented from time to time to describe a specific plan of distribution. In connection with distributions of the shares or otherwise, the Selling Shareholders may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of Subordinate Voting Shares in the course of hedging the positions they assume with Selling Shareholders. The Selling Shareholders may also sell the Subordinate Voting Shares short and redeliver the shares to close out such short positions. The Selling Shareholders may also enter into option or other transactions with broker-dealers or other financial
Index to Financial Statements
institutions which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). The Selling Shareholders may also pledge shares to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution, may effect sales of the pledged shares pursuant to this prospectus (as supplemented or amended to reflect such transaction).
A Selling Shareholder may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by any Selling Shareholder or borrowed from any Selling Shareholder or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from any Selling Shareholder in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, any Selling Shareholder may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.
In effecting sales, broker-dealers or agents engaged by the Selling Shareholders may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from the Selling Shareholders in amounts to be negotiated immediately prior to the sale.
In offering the shares covered by this prospectus, the Selling Shareholders and any broker-dealers who execute sales for the Selling Shareholders may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. Any profits realized by the Selling Shareholders and the compensation of any broker-dealer may be deemed to be underwriting discounts and commissions.
Certain of the Selling Shareholders including F. Ashley May, Thad Beshears, Frederick B. May Family Irrevocable Trust – 2018, John B. May Family Irrevocable Trust 2018, Elizabeth B. May, Elizabeth S. May, Frederick B. May, Peter T. Healy, John B. May Sr., Richard S. May, Susan E Thronson, Jason Pernell, Kim Rivers, Thomas Millner, Shade Leaf Holding, LLC have entered into share distribution agreements with us pursuant to which they have agreed to transfer any securities of the Company that they hold only: (i) pursuant to a block trade or secondary sale organized by the Company or as otherwise approved by us from time to time and (ii) pursuant to an automatic share distribution plan established in accordance with Canadian securities laws and regulations or pursuant to a Rule 10b5-1 plan established in accordance with applicable U.S. securities laws and regulations.
In order to comply with the securities laws of certain states, if applicable, the shares must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the shares may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.
FYI - Neptune Wellness Q4 Sales $11.50M Miss $13.81M Estimate. Now that's a big miss!
Here, if you want a complete understanding pull the previous filings. Right now I’m in 2nd hole fairway waiting for the 4 some to putt out. merger related .
From the SEC filing today-
EXPLANATORY NOTE—DEREGISTRATION OF SECURITIES
On January 12, 2021, the registrant filed a Registration Statement on Form S-1 (Registration No. 333-252052), which was subsequently declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 4, 2021, as amended by Post-Effective Amendment No. 1 to Registration Statement on Form S-1 filed with the SEC on March 23, 2021 and declared effective on March 29, 2021, Post-Effective Amendment No. 2 to Registration Statement on Form S-1 filed with the SEC on September 15, 2021 and declared effective on September 20, 2021, and Post-Effective Amendment No. 3 to Registration Statement on Form S-1 filed with the SEC on January 21, 2022 and declared effective on January 25, 2022 (the “2021 S-1 Registration Statement”).
In addition, on January 21, 2022, the registrant filed a Registration Statement on Form S-1 (Registration No. 333-262299), which was subsequently declared effective by the SEC on January 28, 2022 (the “2022 Registration Statement,” and together with the 2021 Registration Statement, collectively the “Registration Statements”).
This Post-Effective Amendment (this “Post-Effective Amendment”) is being filed to deregister any and all securities that remain unsold under the Registration Statements.
Such Registration Statements registered the offer and sale of up to 70,710,599 subordinate voting shares and 1,577,600 subordinate voting shares, without par value, of Trulieve Cannabis Corp. (the “Company”) by the selling shareholders identified in such Registration Statement.
The Company, by filing this Post-Effective Amendment, hereby terminates the Registration Statements and removes from registration any and all securities registered but unsold under the Registration Statements as of the date hereof. This filing is made in accordance with an undertaking made by the Registrant in Part II of the Registration Statements to remove from registration by means of a post-effective amendment any securities that had been registered for issuance but remain unsold at the termination of the offering.
It was a nice move. Volume was a little light. We'll see what happens friday.
Yep, it’s been a ride. CBD started out full of potential, of speculation, and we jumped on that band wagon. Currently were all caught into the hope it will make it. The last 4 years and what has really occurred would take far to long for me to type out. Sure, some of the talk could be of FDA, covid, competition, poor management, cost structure, but at the end of the day the CBD sector went from managing growth and expectations into a reality of trying to survive. That of course is for the whole sector, not just this company. A lot of us got trapped into what is. Me included.
Well, your right. Nothing is the correct answer. Imaginary deals aside the leadership has not bought in the open market, didn’t buy at 6,5,4,3,2,1, they didn’t buy at 50 cent, 25 cents, 10 cents and now at 3 cents. Since there the ones in the know, it is telling. However, I still have to say congrats to them, they made the right choice not to lose their money.
Re: Never made anywhere close to whole, your likely correct. They currently have nothing, but let’s say it does bump up to .06 cents on a pump. Then it becomes a simple take the 100 percent gain and let the shorts take over. If they do come with something real, let it come, the Momo’s will ride it for a short time, take their profits and be gone, then the shorts will take over. Now IF they ever start selling the product at a solid profit, and they do it repeatedly, then over time they may get whole. I don’t believe they have the horses to pull that off. We’ll see.
A little over a couple of hours to go. 45 trades – 12532 in dollars – 278 per - vwap .03278 In other words another dead day. Some may say look at the volume. Others may say look at the dollars. And yet others may say how much were swaps.
CVSI came out hot right from the gate. Already has 95 dollars in trade, smoking hot!
A lot of green on the screen today, I like it.
LOL and that has been going on for how many years! All the CEO appears to be doing is collecting paychecks
ok, yes your about right. 34,967 in dollars. 95 trades – 368 per trade. A added point to make is the MM’s action, the swaps in trying to create the illusion that it’s trading on it’s own.
The good news is the CEO voted himself in a raise, so we know he will be taken care of.
A little over 1million shares traded. right before close down 15 percent. most others in this sector are up big, MSOS is up 7 percent today. Other than this one it was a great day.
Well you have over 30k invested, that's not to big of a risk. GL